Aims & Scope

Call for Papers

Submit now.

Molecular Informatics will be a peer-reviewed, international forum for publication of high-quality, interdisciplinary research on all molecular aspects of bio/cheminformatics and computer-assisted molecular design. Molecular Informatics will succeed QSAR & Combinatorial Science from 2010 onwards.

Molecular Informatics presents methodological innovations that will lead to a deeper understanding of ligand-receptor interactions, macromolecular complexes, molecular networks, design concepts and processes that demonstrate how ideas and design concepts lead to molecules with a desired structure or function, preferably including experimental validation.

The journal's scope includes but is not limited to the fields of drug discovery and chemical biology, protein and nucleic acid engineering and design, the design of nanomolecular structures, strategies for modeling of macromolecular assemblies, molecular networks and systems, pharmaco- and chemogenomics, computer-assisted screening strategies, as well as novel technologies for the de novo design of biologically active molecules. As a unique feature Molecular Informatics will publish so-called "Methods Corner" review-type articles which will feature important technological concepts and advances within the scope of the journal.

ISSN 1868-1743 (print), 1868-1751 (online)

Editors		Prof. Dr. Knut Baumann Technische Universität Braunschweig Braunschweig, Germany Phone: +49 531 391 2751 Fax: +49 531 391 2799 E-mail: k.baumann@tu-braunschweig.de		Dr. Jordi Mestres Institut Municipal d'Investigació Mèdica Barcelona, Spain Phone: +34 93 316 0540 Fax: +34 93 316 0550 E-mail: jmestres@imim.es
		Prof. Dr. Gerhard Ecker Universität Wien Vienna, Austria Phone: +43-1-4277-55110 Fax: +43-1-4277-9551 E-mail: gerhard.f.ecker@univie.ac.at		Prof. Dr. Gisbert Schneider Goethe-Universität Frankfurt Frankfurt/Main, Germany Phone: +49 69 79 82 48 73 Fax: +49-69 79 82 48 80 E-mail: gisbert.schneider@modlab.de

Readership

Computational chemists and biologists; Medicinal, pharmaceutical, organic and biochemists; Chemical and molecular biologists; Pharmacists and pharmacologists; Drug designers; Researchers in the fields of chem/bioinformatics

Keywords

Cheminformatics, Bioinformatics, Pharmacoinformatics, Drug design, Virtual screening, Molecular modeling, Protein modeling, Protein engineering, Nucleic acid engineering, Pharmacogenomics, Chemogenomics, Systems biology, Small molecules, Macromolecular complexes, Molecular networks, Protein-protein interactions, QSAR

For Authors

• Guidelines
• Keyword Catalogue
• Online Submission of Manuscripts
• EuCheMS Ethical Guidelines
• Keyword Catalogue
• Abbreviations of Journal Titles (CAS)
• Colour Charge Agreement
• Copyright Transfer Agreement: A4 format, US letter format
• Permission Request Form (Wiley/-VCH)
• Request Permission Form (Other Publishers)
• MS Word (Win/Mac) templates for
  • Communications
  • Full Papers
  • Methods Corners
  • Reviews

Contact Us

Publisher		Dr. Carina S. Kniep Fax: +49 6201 606 203 E-Mail: STM-journals@wiley-vch.de	Editorial Assistance		Josefa Fernandez Fax: +49 6201 606 203 E-Mail: STM-journals@wiley-vch.de
Marketing		Monika Silz Fax: +49 6201 606 100 E-Mail: msilz@wiley-vch.de	Production		Sabine Hillenbrand Fax: +49 6201 606 226 E-Mail: SHillenbrand@wiley-vch.de
Publishers		Wiley-VCH Verlag GmbH & Co. KGaA P. O. Box 10 11 61 69451 Weinheim (Germany) Phone: +49-(0)6201-606-400 Fax: +49-(0)6201-606-184 E-Mail: service@wiley-vch.de

Editorial Advisory Board

Dimitris K. Agrafiotis, Johnson & Johnson, PA, USA

Karl-Heinz Baringhaus, Sanofi–Aventis, Frankfurt, Germany

Scott Boyer, AstraZeneca, Mölndal, Sweden

Mark T. Cronin, Liverpool John Moores University, UK

Peter Ertl, Novartis, Basel, Switzerland

Kimito Funatsu, The University of Tokyo, Japan

Robert Glen, University of Cambridge, UK

Andrew C. Good, Genzyme Corporation, Framingham, MA, USA

Paola Gramatica, University of Insubria, Varese, Italy

Wolfgang Guba, F. Hoffmann-La Roche, Basel, Switzerland

Philip J. Hadjuk, Abott Laboratories, Abbott Park, USA

Donald Hilvert, ETH Zürich, Switzerland

Andrew L. Hopkins, University of Dundee, UK

Ad P. IJzerman, Universiteit Leiden, The Netherlands

Hualiang Jiang, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Pudong, Shanghai, China

Dmitry A. Konovalov, James Cook University, Townsville, Australia

Muthukumarasamy Karthikeyan, National Chemical Laboratory, Pune, India

David Lloyd, Trinity College Dublin, Ireland

David Manallack, Monash University, Melbourne, Australia

Jonathan S. Mason, Lundbeck Research, Copenhagen, Denmark

Stefano Moro, Università degli Studi di Padova, Italy

Ingo Mügge, Böhringer Ingelheim, Ridgefield, CT, USA

Tudor I. Oprea, University of New Mexico, Albuquerque, USA

John P. Overington, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK

Stephen D. Pickett, GlaxoSmithKline, Hertfordshire, UK

Brian K. Shoichet, University of California, San Francisco, USA

Sung-Sau So, F. Hoffmann-La Roche, New Jersey, USA

Michael J. E. Sternberg, Imperial College London, UK

Igor V. Tetko, Helmholtz-Zentrum Neuherberg, Germany

Alexander Tropsha, University of North Carolina, Chapel Hill, USA

Alexandre Varnek, Université de Strasbourg, France

Patrick Walters, Vertex Pharmaceuticals, Cambridge, MA, USA

Renxiao Wang, Chinese Academy of Sciences, Shanghai, China

Tanja Weil, National University of Singapore

Jianhua Yao, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, China